Authors
Loading...
Observational analysis shows increased liver cirrhosis risk in carriers of SERPINA1 and PNPLA3 variants, suggesting genetic screening may aid in management.
Holinka et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: